Generic tamsulosin put to the test against Brand-Name drug in healthy volunteers
NCT ID NCT07156916
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 31 times
Summary
This study checks if a generic version of tamsulosin (0.4 mg prolonged-release tablets) works the same as the brand-name drug Omnic Ocas in healthy adult men. Participants take a single dose of each under fasting conditions, and researchers measure drug levels in the blood to confirm bioequivalence. The goal is to ensure the generic is a safe and effective alternative, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER MALE SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
"Tonus-Les" LLC
RECRUITINGYerevan, Ankuk Region, 0037, Armenia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.